Form 4 for IMVT Immunovant, Inc.
Accepted 2022-01-31 00:00:00 ET · period of report 2022-01-28 · accession 0001764013-22-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-31 | 2022-01-28 | IMVT | Levine Mark S. | CLO | A - Grant | $0.00 | +143.0K | 143.0K | New | $0 |
| D | 2022-01-31 | 2022-01-28 | IMVT | Levine Mark S. | CLO | A - Grant | $0.00 | +383.0K | 383.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-28 | A | A | 143,000 | $0.00 | 143,000 | D | — | — | (F1) Represents the number of shares underlying restricted stock units awards ("RSUs"). (F2) The RSUs vest over four years, with 25% of the RSUs vesting on January 19, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. |
| 2 | Derivative | Stock Option (right to buy) | 2022-01-28 | A | A | 383,000 | $0.00 | 383,000 | D | $6.72 · — to 2032-01-28 | 383,000 Common Stock | (F3) Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on January 19, 2023 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. |